Live From New York — It’s MM&M Awards Judging Time!

In June, a small gathering of highly regarded healthcare marketers will meet in a Park Avenue conference center in Manhattan to face a daunting task — select recipients of 2017 MM&M Awards.

These jurors will debate the merits of hundreds of incredibly clever, meticulously planned and exquisitely designed campaigns and their assets to determine who wins these highly coveted awards at the October ceremony. I’m honored and humbled to have been invited by MM&M to serve as a live juror at this June gathering.

The MM&M awards are among the most respected in the healthcare marketing industry. Agencies from around the world compete in nearly three dozen categories to determine best-in-class media and brand programs, outstanding visual and strategic creativity, and exceptional performance within agency teams.

But, I must step back for a moment.

My feelings about awards are somewhat conflicted, and I’m not alone. Award ceremonies generate diverse opinions:

  • “Awards sell tickets, and they’re a clever publicity stunt.” Actor Tony Randall
  • “Awards can give you a tremendous amount of encouragement to keep getting better, no matter how young or old you are.” Actor Alan Alda
  • “I win my awards at the box office.” Director Cecil B. DeMille

I thoroughly analyze the contestants’ data and creative to evaluate their impact and how the campaigns and tactics moved the needle for the brands and consumers. This performance-driven philosophy is fundamental to what I do every day at Arteric. Everything at Arteric revolves around driving results that truly matter to our clients’ business needs. It’s why we focus on determining which data points and KPIs matter most to our clients’ businesses and then build assets to deliver on them. We believe that our work should be measured, analyzed, and judged against real-world results.

As we become better, more-efficient, more-creative communicators, we ultimately enhance the entire industry’s ability to connect with patients and healthcare providers.

One point is unequivocal — there’s tremendous value in gathering with talented peers to analyze the industry’s latest thinking and gauge where it’s heading. Selecting the best work and celebrating at an event puts everyone on notice to the new standards. The cliché is that a rising tide floats all boats. As we become better, more-efficient, more-creative communicators, we ultimately enhance the entire industry’s ability to connect with patients and healthcare providers. As jurors, we establish new baselines and drive innovation and creativity industry wide.

I’ve served as an online juror for the MM&M awards since 2014. The experience was exceptionally rewarding. Discussing and debating the approaches behind the next generation of best practices in person with the industry’s creative and strategic elite is undeniably icing on the cake.

For these reasons, I enthusiastically approach next month’s gathering of jurors and the earth-shaking ideas that will be my privilege to evaluate. Would I love to see more awards on display at Arteric? Sure, what agency wouldn’t? But even then, my favorite awards will remain those that don’t sit on a shelf or hang from a wall — it’s knowing that the work we do every day improves peoples’ lives and helps them to live longer, healthier, and happier.

Arteric Welcomes Kristen Giordano as Interactive Art Director

Arteric (http://arteric.com), a digital healthcare marketing agency that fuses exceptional software development skill with healthcare marketing expertise to help brands connect patients, caregivers and healthcare professionals with the health information and tools that enable patients to live longer, healthier lives is pleased to announce that Kristen Giordano has joined Arteric’s Creative Services team as an Interactive Art Director.

A graduate of New York’s School of Visual Arts, Kristen has helped transform strategic vision into award-winning websites, physician portals, interactive training materials and print materials for consumer and healthcare professional audiences. During Kristen’s near decade of increasing responsibility with Ogilvy CommonHealth, she created multichannel campaign assets that helped build and launch multiple brands, among them, Bydureon®(AstraZeneca), Skula®(Bayer), Xarelto®and Yondelis®(Janssen) and Flonase®(GSK).

“Competition is fierce for creative talent with a proven track record of exceptional design and UX (user experience design) skill applied to healthcare campaigns.” states Hans Kaspersetz, co-founder and president of Arteric. “Adding Kristen’s top-tier agency experience to our expanding Creative Services team further enhances our ability to create transformative experiences for our client’s healthcare brands and campaigns.”

Arteric’s Creative Director, Ross O’Shea, who worked previously with Ms. Giordano at Ogilvy CommonHealth, adds, “We’re very excited to have Kristen join the team. Her work ethic is like no other, and her exemplary design and user experience skill is already creating unique, transformative experiences for our clients.”

Mr. Kaspersetz adds, “Arteric’s mission is to help clients explore the boundaries of what’s possible. To do that, we search for people who aren’t afraid to step up, propose what hasn’t been done before and then find a way to make that happen. Kristen’s track record highlights her ability to do just that.”

Bydureon is a trademark of AstraZeneca Pharmaceuticals LP
Skyla are trademarks of Bayer Pharmaceuticals
Yondellis and Xarelto are trademarks of Janssen Pharmaceuticals, Inc.
Flonase is a trademark of GSK

Arteric Technology Utilized in Hypertension Medication Adherence Study at Baylor College of Medicine

OnTimeRx® Automated Reminder Service Tested in Stroke Prevention Program Targeting African-American Women

Arteric is a digital agency, but ultimately, we’re in the life extension business. By blending exceptional software development skills with healthcare marketing expertise, we help brands and healthcare organizations connect patients, caregivers and healthcare professionals with the health information and tools they need to live longer, healthier lives.

Susan Torrico, a career pharmacist and medication-adherence pioneer, is also in the life extension business. In 2000, after watching too many patients lose their transplanted organs because they didn’t follow their anti-rejection treatment regimens, Susan began experimenting with mobile technology as a method to improve medication adherence. As Susan explains, “It was devastating seeing so many people, especially teens, miss out on an opportunity for a healthier life simply because they didn’t take their medication. At that point, I developed the concept that became OnTimeRx®.”

In 2005, Arteric teamed up with Susan to develop the OnTimeRx® Automated Reminder Service — mobile technology that provides Web-based reminder-scheduling and notification messages that are delivered by text message, phone call or email. The Automated Reminder Service is the most recent addition to the OnTimeRx® adherence software collection, which include apps for the iPhone® and iPad®, for Android smartphones, and for Windows® desktop computers. These software apps provide reminders in the form of alarm sounds and/or on-screen notices as an alternative to text messages, phone calls or email.

We’re very interested in determining if the automated phone and email reminders sent by OnTimeRx® improve medication adherence in this at-risk population. Preliminary results from a very small patient population look promising.

In addition to transplant patients, OnTimeRx® technology has been applied in adherence studies involving HIV treatment in young people. It was inspiring to learn that OnTimeRx® software is now being evaluated in a population at risk for hypertension.1 African-American women are more prone to hypertension than non-African Americans — 47.5% vs 28%.2,3 Medication non-adherence can cause these women to develop a decreased threshold for stroke development or an increased progression of cardiovascular disease.

To address this issue, researchers at the Baylor College of Medicine are implementing the OnTimeRx® Automated Reminder Service in a pilot study investigating the efficacy of smartphone-based services to improve medication adherence.4 The study is funded by The Lone Star Stroke Consortium, which is a Texas-based collaboration of major stroke centers, and the Texas Nursing Association-District 9.

Study researcher Vanessa Monroe, Clinical Assistant Professor at Prairie View A&M University College of Nursing and PhD Candidate at Texas Woman’s University-Houston, shared these thoughts with us. “We’re very interested in determining if the automated phone and email reminders sent by OnTimeRx® improve medication adherence in this at-risk population.” Vanessa continued, “Preliminary results from a very small patient population look promising. We’re in the midst of adding more patients to the study.”

We’ll keep you informed about Vanessa’s progress, because non-adherence remains a vexing challenge, with rates ranging from 30% to 60% depending on the condition, the treatment, the patient and the setting.4 Medication error rates are just as worrisome — 20% to 80% of patients make mistakes and up to 60% of patients stop their medication too soon.Non-adherence also creates an economic burden. The cost of drug-related morbidity and mortality in the ambulatory setting in the United States has been estimated to be as high as $136 billion.5

Nonadherence has many contributing factors, and so presents a moving target. But mobile communication technology is continually evolving, and we’re evolving our platforms and extending OnTimeRx® functionality to help patients and healthcare providers meet the challenge.

LEARN MORE ABOUT ONTIMERX

Software solutions  from apps to enterprise

Arteric connects patients, caregivers, and healthcare professionals to the health information they need to live longer, healthier lives. We achieve this by finding and filling unmet needs with intuitive well designed technologies. However needs change and technology evolves, count on Arteric to combine infinite curiosity, what if? thinking and unstoppable software expertise to develop life-changing custom mobile apps and out-of-the-box-ready enterprise solutions for pharma, biotech and life science marketers and the people that they help

For information about OnTimeRx® products, contact Jon Fisher at 201.546.9902.
For information about the clinical trial, contact Vanessa Monroe at 832.971.8682.

OnTimeRx is a registered trademark of Arteric.
Windows is a trademark of Microsoft Corporation                                             iPhone and iPad are trademarks of Apple Inc., registered in the U.S. and other countries.
Android is a trademark of Google Inc.

References

  1. Monroe V, Dello Stritto R, Langford R, Young A. (2017). Texas Woman’s University-Houston. Testing a Smartphone Application Intervention to Improve Medication Adherence in African American Female Clinic Patients with Unstable High Blood Pressure: A Two Group Randomized Control Trial. Presented at the Southern Nurse Research Society Symposium. Dallas, Texas.
  2. Taylor J, Peternell B, Smith J. (2013). Attitudes toward genetic testing for hypertension among African American women and girls. Nurs Res Pract. 2013;2013:341374. doi:10.1155/2013/341374 
  3. Still C, Craven T, Freedman B, et al. (2015). Baseline characteristics of African Americans in the systolic blood pressure intervention trial. J Am Soc Hypertens. 2015;9(9), 670-679. doi:10.1016/j.jash.2015.06.012
  4. Gottlieb H. Medication Nonadherence: Finding Solutions to a Costly Medical Problem. Medscape. Available at http://www.medscape.com/viewarticle/409940_6. Accessed May 3, 2017.
  5. Johnson J, Bootman J. (1995) Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med (18):1949-56.